Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam
NCT05160987Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Mar 2022
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam in critical illness (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Duration of mechanical ventilation up to 28 days. Started Mar 2022; status: recruiting.
02
Drugs
remimazolam
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT05160987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160987.